5,018
Views
8
CrossRef citations to date
0
Altmetric
Plain Language Summary of Publication

A Plain Language Summary of the ASCENT Study: Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer

, , , , , , , , & show all
Pages 3911-3924 | Received 12 Jul 2021, Accepted 11 Aug 2021, Published online: 01 Sep 2021

Reprints and Permissions

Taylor & Francis does not sell reprints or permissions for this article. Please refer to the 'Licensing' tab on the article menu bar for information on the reuse conditions associated with this license type.